Trademarkia Logo

Canada

C$
ENGTR1S
REGISTERED

on 25 Oct 2024

Last Applicant/ Owned by

GENTIBIO INC.

150 CambridgePark Drive, 9th FloorCambridge MA 02140

US

Serial Number

2168727 filed on 14th Jan 2022

Registration Number

TMA1265361 registered on 25th Oct 2024

Registration expiry Date

14th Jan 2032

Correspondent Address

KELLY LYNNE MOFFATT

(OSLER, HOSKIN & HARCOURT LLP)BOX 501 FIRST CANADIAN PLACETORONTO

ONTARIO

CA

M5X1B8

ENGTR1S

Trademark usage description

gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmun Read More

Classification Information


Class [005]
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders.


Classification kind code

11

Class [040]
Custom manufacture of pharmaceuticals for others; custom manufacturing and engineering of biological cells.


Classification kind code

11

Class [042]
Scientific research, namely, analysis of human and animal tissues and cells for scientific research purposes; scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; scientific research in the field of immune sequencing; scientific research in the field of autoimmune, alloimmune, inflammatory and allergic diseases; pharmaceutical research; medical research; technological consultation services in the fields of manufacturing pharmaceuticals and manufacturing engineering of biological cells; laboratory research services in the field of immunology and cellular engineering.


Classification kind code

11

Mark Details


Serial Number

2168727

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 15th Jun 2023
Search Recorded
Submitted for opposition 20
on 15th Jun 2023
Examiner's First Report
Submitted for opposition 223
on 15th Jun 2023
Total Provisional Refusal
Submitted for opposition 135
on 26th Jan 2023
Amendment to Application
Submitted for opposition 256
on 26th Dec 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 24th Feb 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Feb 2022
Created
Submitted for opposition 31
on 23rd Feb 2022
Formalized
Submitted for opposition 228
on 14th Jan 2022
International Registration
Submitted for opposition 30
on 14th Jan 2022
Filed